Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis.
2021
Abstract Background Vadadustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, a class of compounds that stimulate endogenous erythropoietin production. Methods We conducted two r...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
14
Citations
NaN
KQI